Strides Pharma Science Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue growth of 15.2% in the latest quarter indicates strong demand and market positioning.
Net profit of ₹105.59 crore marks a significant recovery from losses earlier in the year.
Operating profit margin improved to 121.73%, showcasing better cost control and operational efficiency.

NEGATIVES

Expenses increased by 12% compared to the previous quarter, impacting profitability.
Interest expenses remain significant, indicating possible debt management issues.
Profit before tax fluctuated significantly, highlighting instability in overall financial performance.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Jun 25
Revenue	929.99	999.43	1,037.67	1,084.03	1,087.50	1,201.11	1,153.67	1,119.74
Expenses	899.41	984.99	974.37	984.22	999.51	1,097.98	1,043.96	998.01
Operating Profit	30.58	14.44	63.30	99.81	87.99	103.13	109.71	121.73
Other Income	8.64	35.85	8.75	-13.55	12.72	28.41	5.62	8.58
Interest	76.42	78.59	79.28	80.16	80.39	82.15	52.18	47.46
Depreciation	59.59	60.10	51.23	49.76	48.59	50.52	48.42	48.89
Profit Before Tax	0.32	-156.90	10.01	29.62	85.17	114.86	113.84	122.04
Tax	9.68	-7.44	10.10	19.25	16.86	21.20	23.80	16.45
Net Profit	-9.36	-149.45	54.06	10.44	68.31	93.66	90.04	105.59
Eps in Rs	-0.79	-14.54	5.43	1.98	7.64	10.14	9.56	10.81